Login to LiveSLR
Login to MyCytel
Login to CytelStore
Solutions
Drug Development Cycle
Discovery
Phase I-III Clinical Trials
Commercialization
Real-World Evidence Solutions
Strategic Data Science and Analytical Methods
Clinical Trial Design
Trial Delivery
Advanced Analytics
Specialty Areas
Discovery

Our innovative preclinical solutions empower your drug development journey with cutting-edge analytics and insights from inception to preclinical stages.

Find out more
Phase I-III Clinical Trials

We help you navigate complex trial phases efficiently with data-driven methods & strategies tailored to Phase I-III trials for accelerated drug development.

Learn more
Commercialization

Maximize your market potential and optimize your commercial strategies with our advanced analytical methods, data science, and tailored commercialization solutions for data-driven commercial success.

Learn more
Real-World Evidence Solutions

Harness the power of real-world data and real-world evidence to gather insights and shape future drug development cycles for enhanced efficacy and regulatory compliance.

Find out more
Clinical Trial Design

Craft optimal trial designs with our advanced analytical methods to enhance efficiency and increase the probability of success throughout your drug’s lifecycle.

Learn more
Trial Delivery

Empower your trial delivery by transforming trial designs into actionable strategies with our data-driven approach to ensure seamless delivery and successful outcomes.

Find out more
Advanced Analytics

Unlock the power of data with our methods for actionable insights to drive informed decisions and optimize clinical trial outcomes.

Learn more
Specialty Areas

We offer tailored analytics solutions for your specialized or niche projects enabling you to optimize both efficiency and precision in drug development.

Learn more
Quick Links
Data Strategy Model-lnformed Drug Development Chemistry, Manufacturing and Controls (CMC) Toxicology Solutions Clinical Pharmacology, Drug Metabolism and Pharmacokinetics
Adaptive Trial Designs Complex and Innovative Trial Design Model-lnformed Drug Development Clinical Development Strategy and Planning End-to-End Biometrics Axio® Data Monitoring Committee Data Strategy Regulatory Strategy Market Access Real-World Evidence Software for Trial Design
Health Economics and Outcomes Research (HEOR) Market Access Regulatory Strategy Real-World Evidence Health and Technology Assessments stève consultants
Real-World Evidence Real-World Data Real-World Data Software Post-Authorization Safety Studies stève consultants
Adaptive Trial Design Complex and Innovative Trial design Model-lnformed Drug Development Software for Trial Design
End-to-End Biometrics Data Management Early Phase Solutions Late Phase Solutions Axio® Data Monitoring Committee Safety & Regulatory Compliance FSP Outsourcing Outsourcing per Project Software for Trial Implementation
Systematic Literature Reviews Complex and Innovative Trial Design Market Access Health Economics & Outcomes Research Real-World Evidence Real-World Data Health and Technology Assessments
Synthetic Controls External Controls Rare Diseases Oncology Post-Authorization Safety Studies Decentralized Trials Pediatrics
Delivery Models
Strategic Consulting
Beyond Functional Service Provider
Project-Based Analytical Solutions
Software Solutions
Trial Design Software
Trial Implementation and Decision Support Software
LiveSLR® Software for Systematic Literature Reviews
Strategic Consulting

Enhance your clinical trial design with our strategic consulting services, featuring adaptive trial models and comprehensive regulatory guidance to ensure innovative, compliant, and successful trial outcomes.

Learn more
Beyond Functional Service Provider

Experience the future of flexible strategic partnerships with Analytics on Demand, providing adaptive and innovative solutions that transcend traditional models to achieve unparalleled operational excellence.

Learn more
Project-Based Analytical Solutions

Maximize efficiency and outcomes with our project-based services, delivering specialized expertise, end-to-end biometrics, and focused solutions for unique projects, ensuring timely completion and exceptional results.

Project-Based Analytical Solutions
Trial Design Software

Cytel's software platform enables precise trial design and simulation, utilizing adaptive and Bayesian tools to optimize protocols and accelerate drug development with confidence and efficiency.

Learn more
Trial Implementation and Decision Support Software

Our unique software package streamlines trial implementation with intuitive solutions for protocol development, randomization, and patient management, optimizing operational efficiency and ensuring study success.

Learn more
LiveSLR® Software for Systematic Literature Reviews

Learn more
Quick Links
Adaptive Trial Designs Advanced Analytics Regulatory Strategy Clinical Development Strategy & Planning Discovery and Pre-clinical Clinical Pharmacology, drug metabolism and pharmacokinetics
Staff Augmentation Strategic Capacity Management Functional Service Provider Hybrid FSP Model
Data Management End-to-End Biometrics Data Submission support Axio® Data Monitoring Committee Medical Writing
East Horizon™ Platform for Trial Design Xact software suite, StatXact®
Enforesys
About Us
About Us

Learn about our rich history, visionary leadership, and core values. Our mission and vision drive us to deliver excellence in drug development globally.

Learn more
Quick Links
Our Experts Leadership Team Innovation Advisory Board
 
Board of Directors Sustainability
Insights
Insights

Explore Cytel’s Insights hub - your source for the latest news, event updates, and expert insights on advanced data analytics and data science.

Explore now
Quick Links
Perspectives News and Events Resource Library Publications
 
Careers
Careers

Join our innovative team at Cytel! Explore exciting career opportunities in data science and statistics, analytical methods, and regulatory strategy. Advance the future of human health with us.

Learn more
Quick Links
Connect with Us Join our Talent Network Find our Latest Opportunities
 
Contact Us
Contact us
Contact Us
Customer Support
Customer Support
Login to LiveSLR
Login to MyCytel
Login to CytelStore
Contact us
Contact Us
Customer Support
Customer Support

Real-world characteristics and outcomes of patients with multiple myeloma treated with belantamab mafodotin: a German claims data study. Luna J, d’Estrube T, Jacobsen A, Lehne M, Wellmann-Pichler B, Mevius A, Dornig S. Ann Hematol. 2025

Cost-effectiveness analysis of 20-valent anti-pneumococcal vaccination in the Spanish pediatric population. García FÁ, Martinón-Torres F, Pineda V, López-Ibáñez de Aldecoa A, Gálvez P, Ta A, Perdrizet J. Expert Rev Pharmacoecon Outcomes Res. 2025

Treatment Effect Estimation With Potential Outcomes for a Single-Arm Trial Compared With Historical Controls: A Case Study of Locally Recurrent Head and Neck Squamous Cell Carcinoma Patients Treated With Adjuvant Nivolumab. Harun N, Sparapani R, Laud PW, Sivaganesan S, Leddon JL, Haque S, Tang AL, Wise-Draper TM. Head Neck. 2025

Effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on maternal gestational weight gain in low-income and middle-income countries: a systematic review and individual participant data meta-analysis of randomised clinical trials. Liu E, Partap U, Shinde S, Wang D, Costa JC, Cliffer IR, Wang M, Nookala SK, Subramoney V, Briggs B, Hamer DH, Akurut H, Argaw A, Ashorn U, Chinkhumba J, Desai M, Divala TH, Elliott AM, Gutman JR, Hien A, Huybregts L, Kajubi R, Kakuru A, Kariuki S, Lachat C, Laufer MK, Luntamo M, Maleta K, Mathanga DP, Ochieng T, Ome-Kaius M, Patson N, Roberfroid D, Rogerson SJ, Toe LC, Unger HW, Webb EL, Fawzi WW. EClinicalMedicine. 2025

Parent-of-origin effects in the life-course evolution of cardiometabolic traits. Wagh R, Hatem G, Andersson J, Kunte P, Bandyopadhyay S, Yajnik CS, Prasad RB. Diabetologia. 2025

Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Zamulko O, Karivedu V, Riaz MK, Monroe I, Romano A, Mulanda R, Kurtzweil N, Forsythe A, Allen CL, Harun N, Pan J, Rai S, El-Gamal D, Wise-Draper TM. Cancer Research Communications. 2025

Real-world survival outcomes, treatment patterns, and impact of PD-L1 expression among patients with unresectable, stage III NSCLC treated with CRT → durvalumab in Canada: The RELEVANCE study. Wheatley-Price P, Navani V, Pabani A, Routy B, Snow S, Denault MH, Kim Y, Syed I, Devost N, Hui D, Qadeer RA, Arora P, Velummailum R, Springford A, McKibbon C, Ho C. Lung Cancer. 2025

Matching-Adjusted Indirect Comparison of Sotorasib Versus Adagrasib in Previously Treated Advanced/Metastatic Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation. Chopra D, Lan Z, Waterhouse DM, Wolf J, Felip E, Moradian H, Karim N, Obiozor C, Stollenwerk B. Advances in Therapy. 2025

Impact of Seton Use on Clinical, Patient-Reported, and Healthcare Resource Utilization Outcomes in Complex Crohn’s Perianal Fistulas: A Systematic Literature Review. White I, Karki C, Geransar P, Leisle L, Junker S, Fleshner P. Inflammatory Bowel Diseases. 2025

Evaluating the impact of population-based and cohort-based models in cost-effectiveness analysis: a case study of pneumococcal conjugate vaccines in infants in Germany. Perdrizet J, Schröder D, Kühne F, Schiffner-Rohe J, Laurenz M, Theilacker C, Ilic A, Ta A, von Eiff C. Journal of Medical Economics. 2025

Newer Posts
Older Posts